Login / Signup

The efficiency of single institutional review board review in National Institute of Child Health and Human Development Cooperative Reproductive Medicine Network-initiated clinical trials.

Michael P DiamondEsther EisenbergHao HuangChristos CoutifarisRichard S LegroKarl R HansenAnne Z SteinerMarcelle CedarsKurt BarnhartTracy ZiolekTracey R ThomasKate MaurerStephen A KrawetzRobert A WildJ C TrussellNanette SantoroHeping Zhangnull null
Published in: Clinical trials (London, England) (2018)
A single institutional review board reduced time for initial review and approval of protocols and informed consents, although time for the entire process was increased, as individual institutions retained oversight of components of required regulatory review. In order to best achieve the National Institute of Health's goals for improved efficiency in initiation and conduct of multisite clinical research, greater coordination with local institutional review boards is key to streamlining and accelerating initiation of multisite clinical research.
Keyphrases
  • clinical trial
  • healthcare
  • public health
  • endothelial cells
  • randomized controlled trial
  • global health
  • phase ii